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Abstract: Ultrasmall superparamagnetic iron oxide (USPIO) particles are maghemite or 
magnetite nanoparticles currently used as contrast agent in magnetic resonance imaging. The 
coatings surrounding the USPIO inorganic core play a major role in both the in vitro stabil-
ity and, over all, USPIO’s in vivo fate. Different physicochemical properties such as ﬁ  nal 
size, surface charge and coating density are key factors in this respect. Up to now no precise 
structure – activity relationship has been described to predict entirely the USPIOs stability, as 
well as their pharmacokinetics and their safety. This review is focused on both the classical 
and the latest available techniques allowing a better insight in the magnetic core structure and 
the organic surface of these particles. Concurrently, this work clearly shows the difﬁ  culty to 
obtain a complete physicochemical characterization of USPIOs particles owing to their small 
dimensions, reaching the analytical resolution limits of many commercial instruments. An 
extended characterization is therefore necessary to improve the understanding of the properties 
of USPIOs when dispersed in an aqueous environment and to set the speciﬁ  cations and limits 
for their conception.
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Introduction
Superparamagnetic nanoparticles are currently used as contrast agent in magnetic 
resonance imaging (MRI) (Bonnemain 1998; Sonvico, Dubernet et al 2005). They are 
originally ferromagnetic substances which have lost their permanent magnetism due to 
their small size. The magnetization of such nanoparticles follows an external magnetic 
ﬁ  eld without any hysteresis and they are better known as “superparamagnetic” due to 
their large magnetic susceptibility (Lawaczeck et al 2004; Corot et al 2006).
These nanoparticles consist of a coated iron oxide core (magnetite, maghemite or 
other insoluble ferrites) characterized by a large magnetic moment in the presence of 
a static external magnetic ﬁ  eld. They are classiﬁ  ed into two main groups according to 
their size (Bowen et al 2002; Mornet et al 2005; Roch et al 2005; Corot et al 2006).
•  SPIOs (superparamagnetic iron oxides), whose nanoparticles have a hydrodynamic 
size greater than 50 nm (coating included). These nanoparticles have in common 
their speciﬁ  c uptake by the mononuclear phagocyte system (MPS). For example, 
Endorem® and Resovist® are European commercial names of SPIOs available on 
the market for intravenous use. Their clinical targets are liver tumor and metastasis 
(Reimer and Tombach 1998).
•  USPIOs (ultrasmall superparamagnetic iron oxides) (Clement et al 1998), whose 
nanoparticles are smaller than 50 nm (hydrodynamic size coating included). After 
intravenous administration, these devices can be related to long-circulating “stealth” 
nanoparticles and will be the subject of this review.International Journal of Nanomedicine 2007:2(4) 610
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USPIOs are composed of an iron oxide core with a 
crystal size measuring generally less than 10 nm. The size 
will control the T2/T1 relaxivity (Weissleder et al 1990) and 
therefore the signal in MRI which is the key factor for the 
quality of the diagnosis. It should be noted that the relax-
ation mechanisms of USPIOs have been widely treated in 
the literature (Gillis and Koening 1987; Muller et al 1992; 
Roch et al 1999) even though the relaxation process in the 
presence of some magnetic compounds is still on debate 
(Gossuin et al 2002).
The coatings, surrounding the USPIO inorganic core, 
play a major role in both the in vitro stability and, over all, 
USPIO’s in vivo fate. According to the polymer(s) or small 
organic molecule(s) chosen and to its (their) interaction with 
the core, the system will feature different physicochemical 
properties such as ﬁ  nal size, surface charge, density of cover-
ing, etc (Corot et al 2006).
Owing to their small ﬁ  nal size and their hydrophilic coat-
ing, USPIOs are generally able to avoid the early and massive 
uptake by the macrophages from the MPS (especially spleen 
and liver macrophages). This confers to them long circulating 
properties in the bloodstream after intravenous administra-
tion, as well as the possibility of targeting macrophages in 
the deep compartments (Raynal et al 2004). Hence, these 
systems can be used for blood pool imaging where their 
effects on the T1 relaxation time will be exploited. They 
will also be useful for detecting inﬂ  ammatory or degenera-
tive disorders associated with the spread of macrophages 
in which they depict negative enhancement properties on 
T2-weighted sequences. For example, USPIOs will allow 
the detection of lymph node metastasis (Leenders 2003) 
or vulnerable atherosclerotic plaques (Corot et al 2004). 
Important clinical indications in CNS pathologies such as 
stroke, brain tumor proliferation, multiple sclerosis, spinal 
cord injury are also currently developed with USPIOs (Corot 
et al 2004). Furthermore, ex vivo labeling of progenitor and 
stem cells which can be subsequently tracked in vivo with 
MRI will also be a ﬁ  eld of application of iron oxide USPIOs 
nanoparticles (and also SPIO). Hence, given the broad pos-
sible clinical indications of these systems, it is expected that 
USPIOs should be launched on the market in a near future, 
as depicted by Sinerem® whose phase 3 clinical trials have 
been recently achieved.
With regard to the synthesis of magnetic nanoparticles, 
numerous methods have been reported (Pascal et al 1999; 
Jolivet 2000; Tartaj et al 2003; Cushing et al 2004; Gupta 
and Gupta 2005; Tartaj et al 2005). The synthesis most com-
monly used involves an alkaline co-precipitation of ferrous 
and ferric ions in aqueous solution (Babes et al 1999), in 
the presence of a stabilizing agent (for example, dextran). 
Noteworthy, stabilization may also be achieved after the 
synthesis by the single surface adsorption of these agents 
(Ohgushi et al 1978; Molday and Mackenzie 1982; Kim 
et al 2005). However, in terms of chemical synthesis, it is 
still challenging to obtain magnetic particles with a narrow 
monodisperse population for large scale clinical uses.
Moreover and quite importantly, there is no precise 
structure – activity relationship to make it possible to predict 
entirely their stability, as well as their pharmacokinetics, 
biodistribution, metabolism, clearance from the vascular 
system in vivo and their safety. The multiple components 
which govern the properties of the USPIOs should hence 
be characterized as accurately and as broadly as possible, in 
order to better understand their future particular behavior.
Complete physicochemical characterization of USPIOs 
particles is difﬁ  cult, due to their small dimensions. Com-
mercially available instruments are sometimes unsuitable to 
study the complex composition of the USPIOs and problems 
associated with the analytical resolution limits of the appa-
ratus can often occur too.
Hence, this paper will focus on the composition of 
USPIOs, which exhibit very different properties from those 
of the bulk material. This review will also detail the classical 
and the latest available techniques which can be applied to 
have a better insight in their magnetic core structure and their 
organic surface. This will allow to improve the understanding 
of the physicochemical properties of these small magnetic 
particles and to set the speciﬁ  cations and limits for the con-
ception of USPIOs. This will also greatly help to deﬁ  ne and 
develop models of structure-activity relationship.
Morphology and structural 
characterization of the magnetic 
core
The morphological characteristics and size distribution 
of nanoparticles samples are generally observed by TEM. 
Since high resolution transmission electron microscopy 
(HRTEM) has the ability to resolve the atomic arrangement 
in nano size area, it has been employed to investigate 
interfacial local microstructures of the nanoparticles. This 
technique has demonstrated the capability of characterizing 
lattice deformation in a very thin layer (Peng et al 2004). 
HRTEM images were successfully employed to describe the 
crystallography (ie, ideal and real structure: lattice fringes 
characteristic, glide plane, screw axis, lattice vacancies International Journal of Nanomedicine 2007:2(4) 611
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and defects, as well as shape) of crystalline nanoparticles 
(Morales et al 1999; Hyeon et al 2001; Serna et al 2001; 
Miser et al 2004; Brice-Profeta et al 2005).
One of the most discussed (and a controversial) aspect of 
the structural characterization of an USPIO sample is to deﬁ  ne 
the real limit that exists between an ordered (crystalline) 
phase and a disordered (amorphous) phase. From the physi-
cal point of view, a crystal is a solid having a highly regular 
atomic structure in which the atoms are packed in a regular 
order by three-dimensional pattern repeating of atoms. The 
surface of the crystal has to be considered as a boundary 
region where there is a layer constituted by incomplete cells 
due to the breakdown of the crystalline growth.
The limit between a crystal and an amorphous sample 
could be positioned when the surface layer became preva-
lent in respect to the whole sample volume. Nevertheless 
the small particles, measuring less than 10 nm, exhibit high 
surface/volume ratio and are commonly named nanocrystals. 
Up to now this deﬁ  nition is attributed without clear physical 
evidences since the properties of these materials are very 
different from those of the bulk materials (Figure 1).
In the smallest particles it is possible to recognize the 
cationic disorder, disordered surface layer and short-range 
order inside the whole volume. The USPIO particles contain 
a limited number of cubic cell units and, for the above 
reasons, the crystal deﬁ  nition is not completely correct. 
These nanosystems may be considered to be a less-ordered 
system which is neither completely crystalline nor com-
pletely amorphous and their core characterization is difﬁ  cult; 
the combination of various analysis techniques is needed 
(Di Marco et al 2006).
The most important methodology for nanoparticles 
structure characterization is the X-ray diffraction using 
both conventional and synchrotron radiation sources. Ther-
mal analysis, Mossbauer (Serna et al 2001) and Infra Red 
spectroscopy (Morales et al 1999) provide additional useful 
information.
Most of these techniques require the drying of the samples 
whereas for pharmaceutical application, the nanoparticles need 
to be dispersed in a liquid. Drying the sample and placing it 
on/or near a surface might induce some signiﬁ  cant changes 
concerning the physicochemical characteristics of USPIO 
which can be displayed by the occurrence of irreversible 
particles aggregation, for example. Thus, the results obtained 
may not accurately reﬂ  ect the nature of the species in the 
liquid dispersion. Interestingly, nanoparticles can be charac-
terized as a liquid suspension mainly by small angle X-ray 
and neutron scattering (Shen et al 2001; Moeser et al 2004). 
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Figure 1 The ﬁ  gure shows how the number of atoms in the sphere volume and the one in a superﬁ  cial layer differently increase growing the nanoparticle dimension. 
The ratio, in the inset, shows that the number of atoms in the surface layer is prevalent in the smallest nanoparticles.International Journal of Nanomedicine 2007:2(4) 612
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Energy Dispersive X-ray Diffraction (EDXD), suitable for 
the systems with a low degree of crystallinity, (Caminiti et al 
1999; Atzei et al 2001; Sadun et al 2002) is also relevant for 
the structural analysis of nanoparticles even in suspension 
(Di Marco et al 2006).
The above cited difﬁ  culty in determining the real nature 
of nanoparticles, crystal or amorphous phase is reﬂ  ected 
in a series of discordant data when various methodologies 
are used. For example, the mean diameter of the particles 
obtained from electron microscopy is often compared to 
the mean diameter from X-ray diffraction and to the mag-
netic size obtained by the Langevin function treatment of 
the magnetization curve. While there is quite satisfying 
concordance between the dimensions obtained with TEM 
and traditional x-ray analysis, often the values obtained for 
the same sample between these two methods and magnetic 
data are fairly different. The magnetic diameter is gener-
ally smaller than the diameter obtained by TEM. Despite 
the fact that several reasons could be outlined to justify 
this discrepancy, as the presence of particles interactions 
and particle size distribution that can bring deviation from 
the Langevin function, a structural disorder contribution 
seems to be more likely, especially for the smallest particles 
(Morales et al 1997; Serna et al 2001; Batlle and Labarta 
2002; Chatterjee et al 2003; Iglesias and Labarta 2004). 
Magnetization measurements have shown that the satura-
tion magnetization of γ-Fe2O3 nanocrystals, small enough to 
show superparamagnetic properties, decreases with decreas-
ing particle size. However, such reduction is difﬁ  cult to be 
interpreted by considering only the ﬁ  nite size and surface 
effects (Morales et al 1999). To explain this phenomenon 
several hypotheses, even those concerning the cationic 
disorder in the entire volume of the crystal structure, have 
been proposed. There is, however, no unequivocal way for 
clearly differentiating the individual contributions arising 
from ﬁ  nite-size, surface effects and structure of the particles. 
Different magnetic properties have been observed in materi-
als with similar nominal grain-size but produced by different 
synthetic routes thus making the study of the interrelation 
between microstructure and magnetism very interesting. 
A possible explanation is that various syntheses may lead to 
particles having the same size magnitude order but different 
structural coherence in the whole particle volume (Serna et al 
2001). There is no abrupt breakdown in atomic order, but it 
is present in a three-dimensional lattice distortion due to the 
defects and ﬁ  nite size resulting in different magnetization 
values (Di Marco et al 2006). Some authors have reported 
that even the stabilizing agent could inﬂ  uence the structure 
of the particles and, thus, the magnetizations value (Yee et al 
1999; Tartaj et al 2006).
Functionalization of metal oxide 
surfaces
The medical applications of ferroﬂ  uids require stable for-
mulated suspensions. Because of the high speciﬁ  c surface 
area of these ﬁ  ne particles, the contact between the surface 
and the aqueous dispersion medium is very extensive, and 
besides, the interface is very reactive.
In the absence of an efﬁ  cient surface coating, the forma-
tion of agglomerates and aggregates result from the attraction 
forces between the magnetic nanoparticles (mainly van der 
Waals) which can destabilize the suspension.
After their intravenous administration, particles with 
hydrophobic surfaces are efﬁ  ciently covered with plasma 
components especially proteins (opsonisation) and are rap-
idly removed from the circulation by the reticulum endothe-
lial system (RES), whereas particles that display hydrophilic 
surfaces can resist to the opsonisation process, being cleared 
more slowly from the blood compartment (Gaur et al 2002). 
In order to prevent particles aggregation and to improve their 
hydrophilicity as well as to address them to certain cells in 
a speciﬁ  c manner, it is possible to modify the iron oxide 
surface using biocompatible ligands and/or polymers which 
are attached at the particle surface by physical or chemical 
adsorption (Sonvico, Mornet et al 2005). The coating of the 
inorganic cores by polymers or small organic molecules 
also reduces the aging effects observed at their surfaces (as 
oxidation processes or formation of complexes with ions in 
solution) that may turn the surface of a material into a dif-
ferent one (Plaza et al 2002).
Moreover, the physicochemical surface properties of 
USPIOs strongly interfere with their capacity to be internal-
ized by the macrophages or other phagocytic cells following 
their intravenous administration. Consequently, the presence 
of the coating is fundamental to modulate the USPIOs fate 
by masking and controlling their electrical surface properties 
(Arias et al 2001, 2006).
Ferumoxtran-10 which has a small hydrodynamic 
diameter (15–30 nm) shows a prolonged blood residence 
time which allows those USPIO to access macrophages 
located in deep and pathologic tissues (such as lymph 
nodes, kidney, brain, osteoarticular tissues, etc) (Corot et al 
2006). Other USPIOs such as ferucarbotran or VSOP (very 
small superparamagnetic iron oxide particles) have a more 
important liver uptake associated with a faster blood clear-
ance and, consequently, a more limited access to the deep International Journal of Nanomedicine 2007:2(4) 613
Physicochemical characterization of USPIO
compartments (Taupiz et al 2004). Conversely, feruglose 
(Clariscan®), because of the pegylation of the coating starch, 
can be regarded as true “stealth nanoparticles” which are 
hardly recognized by the macrophage-monocytic system and 
probably not suitable for macrophage imaging (Bjornerud 
et al 2001).
Generally, coating agents which are physically adsorbed 
(by electrostatic interactions or hydrogen bounding) show 
limited stability in comparison to coating agents which are 
chemically adsorbed. Indeed, physical adsorption is sensi-
tive to the surrounding medium since competition with other 
macromolecules generally occurs. However, the problem of 
distinguishing between chemical and physical adsorption is 
basically the same as that of distinguishing between chemi-
cal and physical interaction in general. No absolutely sharp 
distinction can be made and intermediate cases exist, for 
instance, adsorptions involving strong hydrogen bonds or 
weak charge transfer. The stability of the coating grafting also 
depends on the quantity of the chemical interaction that each 
individual molecule or macromolecule can establish with 
the surface of the nanoparticle. As a result, each interaction 
between coating and metal oxide surface has to be analyzed 
and discussed in an individual basis.
Different types of coating can be investigated and the 
choice of the appropriate one depends on many factors and 
principally on the clinical purposes of the functionalized 
particle. The most common coatings for biocompatible iron 
oxide suspensions are polymers such as derivatives of dextran, 
carboxymethylated dextran, carboxydextran or polyethylene-
glycol but also starch, arabinogalactan, glycosaminoglycan, 
organic siloxane, sulphonated styrene-divinylbenzene, 
poly(lactic acid), poly(e-caprolactone) and polyalkylcyanoac-
rylate (Zhang et al 2002; Arias et al 2005; Flesch et al 2005; 
Corot et al 2006; Gomez-Lopera et al 2006).
The effect of some chemical modiﬁ  cations of dextran 
on formation and stability of dextran-coated ultrasmall 
superparamagnetic iron oxides (USPIO) has been explored, 
and it has especially been demonstrated that reduction of 
the terminal reducing sugar can have a signiﬁ  cant effect on 
particle size, coating stability, and magnetic properties. For 
low molecular weight dextrans (MW < 10 kDa), reduction 
resulted in a 10 fold or greater decrease in the carbohydrate-
to-iron ratio necessary during particle formation to produce 
the desired particle size (<20 nm) in the coprecipitation pro-
cess (Paul et al 2004). Particles prepared with carboxyalkyl 
ether of a polysaccharide (Maruno and Hasegawa 1993) 
especially reduced dextran yielded a more stable coating as 
evidenced by stability on autoclaving (Groman et al 2003).
Considering the wide use of dextran-coated particles in 
biological applications, it is surprising that the nature of the 
interaction between this coating and iron oxide surface has 
not been more extensively investigated (Jung 1995; Bautista 
et al 2005). No evidence of strong chemical adsorption was 
observed by FTIR (Fourier transform infrared spectroscopy) 
and SSIMS (statistic secondary ion mass spectra) spectra 
analysis (Jung 1995). Both analyses suggest that the dextran 
is not covalently bonded to the iron oxide surface. Moreover, 
the spectra obtained by SSIMS, which is a surface selec-
tive analysis, show the presence of Fe+ ions indicating an 
incomplete surface coverage of the iron oxide particles by 
the dextran layer. It is suggested that the interaction occurs 
through multiple hydrogen bonds between the polymer 
hydroxyl groups and the surface of iron oxide particles.
The nature of the interactions between the dextran and 
the iron oxide nanoparticle surface and its evolution with 
temperature has been investigated by thermogravimetric 
and differential thermal analyses and by coupling these data 
with FTIR spectra analysis (Bautista et al 2005). Just after 
heating, it was observed that carboxylate bonds between 
dextran and iron oxide surface could form by oxidation and 
partial water elimination, a chemical process that probably 
reinforce the stability of the coating. However, even in this 
study, the suggested dominant mechanism was the formation 
of collective hydrogen bonding between dextran hydroxyl 
groups and iron oxide particle surface. Noteworthy, these 
dextran-coated iron oxide particles do not show any long-
term toxicity (Anzai et al 1994; Bellin et al 1998; Clément 
et al 1998; Bellin et al 2000; Bourrinet et al 2006). However, 
it was also observed that dextran-coated USPIO, should not 
always present sufﬁ  cient cellular uptake to enable cell track-
ing due to their small sizes leading to relatively inefﬁ  cient 
ﬂ  uid phase endocytosis pathway (Berry and Curtis 2003). As 
a result, other surface-modifying agents have been explored 
to increase stability of magnetic nanoparticle.
In order to obtain a strong conjugation of dextran to the 
maghemite surface, Mornet et al (2005) have developed 
an original synthetic route. Versatile ultrasmall superpara-
magnetic iron oxide particles (VUSPIO) were obtained in 
a multistep procedure consisting of colloidal maghemite 
synthesis, surface modiﬁ  cation by silanation of the iron core 
with aminopropylsilane groups and covalent conjugation 
with partially oxidized dextran and subsequent reduction 
of the shiff base (Zhang et al 2002; Mornet et al 2005). 
The bonding nature of organosilanes to iron surfaces is 
generally analyzed by FTIR-reﬂ  ection absorption spectros-
copy and secondary ion mass spectroscopy (ToF-SIMS). International Journal of Nanomedicine 2007:2(4) 614
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The Si–O–Fe bond is commonly described as covalent even 
though the discussion on this topic is still open (Wapner and 
Grundmeier 2005). Silanes are an example of a powerful and 
highly ﬂ  exible approach to design functional metal surfaces 
by self-assembled monolayers (SAMs).
Such systems are ordered molecular assemblies formed by 
the adsorption of an active molecule (siloxane, carboxylates, 
thiolates, phosphate etc) on a solid surface (as iron oxide) with 
different terminal groups (usually −OH, −COOH, and −NH) 
(Ulman 1996; Chen et al 2001; Love et al 2005). Figure 2 
shows a SAMs model where the active part is a carboxylate 
with generic terminal groups R. These R functional groups are 
not always necessary as in the case of long-chain fatty acids 
self-assembled monolayers (Figure 3) (R=CH3).
Self-assembled monolayers enable to control surface 
properties, the terminal groups allowing further function-
alization by chemical reactions. These functionalities are 
also frequently incorporated in various polymers where 
attachment of species on the surface is desired (as the dex-
tran grafted with siloxanes described above). SAMs can be 
prepared simply by adding a solution of the desired molecule 
onto the substrate suspension and washing off the excess not 
adsorbed onto particles surfaces. Their stability depends basi-
cally on the afﬁ  nity of the active molecule for the substrate 
(solid surface), pH and ionic strength of the environment.
SAMs are currently the subject of intensive studies due to 
their potential applications as particles coatings. However the 
basic mechanisms of adhesion of this kind of molecules onto 
metal surface are not yet satisfactorily understood, mainly due 
to limited understanding of the adhesive-surface interactions. 
Of course, the study of these phenomena requires a detailed 
knowledge of the surfaces and of the molecules to be studied 
(Tirrell et al 2002).
Carboxylic acids may be adsorbed on many metal oxides 
but their interactions are weak, except for long-chain fatty 
acids which form a dense monolayer and are widely used 
in metal oxide nanocrystal syntheses. The mechanism of 
adsorption of dimercaptosuccinic acid (DMSA) has been 
studied by conductimetric measurements and adsorption 
isotherms curves. DMSA is oxidized during the coating 
process in tetrameric polysulﬁ  de chains [DMSAox]4 which 
are absorbed by the carboxylate moiety on the particles 
after alkalisation and neutralisation. The obtained particles 
are stable particles at pH = 7 (Fauconnier et al 1997; Roger 
et al 1999).
The interaction between various anions and hydrated 
oxide particles has been investigated in many studies; the 
reactive groups including phosphates and phosphonates 
were used to form monolayers on a wide range of transition 
metal oxide surfaces having high afﬁ  nity especially for those 
containing aluminium and iron oxide (Brovelli and Hähner 
1999; Textor et al 2000; Kreller et al 2002; Borggaard et al 
2005). Several studies are reported in the literature which 
demonstrated that phosphonates and phosphates bind efﬁ  -
ciently to iron oxide particle surfaces and can serve, in gen-
eral, as potential alternatives to fatty acids as coating agents 
for metal oxide surface (Chen et al 2001; Sahoo et al 2001; 
White et al 2006). Moreover, functionalized phosphonate 
Figure 2 (a) A model of SAMs grafted onto nanoparticle surface, the active part being a carboxylate carrying a generic terminal groups R. (b) A detail of the nanoparticle 
showing an interaction schema between carboxylate SAMS and the ﬁ  rst layer atoms of the iron oxide surface.International Journal of Nanomedicine 2007:2(4) 615
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and phosphate seems to have an acceptable biocompatibility 
(Auernheimer et al 2005) and it is possible to suggest their 
utilization as coating agents of magnetic nanoparticles in 
medical applications.
Phosphonates are molecules that contain one or more 
R−PO(OH)2 Lewis acid groups. The P−C bond is generally 
very stable toward oxidation or hydrolysis so that many 
reactions can be carried out on the rest of the organic part 
of the molecule. These compounds not only possess a very 
high ability to form strong complexes with transition met-
als in aqueous solution with stability constant (log K values 
between 14 and 23) but also show a large afﬁ  nity for the metal 
oxide surfaces (Martell et al 1997; Barja et al 2001). As a 
result, there has been an increasing interest in monolayers 
of long-chain phosphonic acids or alkylphosphoric acids. 
Another advantage is that the preparation of alkylphosphonic 
acids or alkylphosphoric acids is quite easy. The adsorp-
tion interactions of phosphate on iron oxide surfaces are 
complex and still discussed even if a variety of analytical 
methods have been employed for their investigation. The 
most widely used are methodologies in which removal of 
species from a solution following their adsorption onto the 
iron oxide particles is monitored through the determination of 
the species concentration prior to and after equilibrium with 
suspended solids has been reached (Zeng et al 2004). Infrared 
spectroscopy (IR) has been employed extensively to study 
phosphate adsorption on oxide surfaces (Tejedor-Tejedor 
and Anderson 1990; Persson et al 1996; Nowack and Stone 
1999). This technique has provided important insight into 
the identity of active surface sites involved in phosph(on)ate 
adsorption as well as the structures of the adsorbed species. 
Furthermore, the infrared features of phosphate are in a very 
characteristic way dependent on the symmetry of the ion, 
and it is therefore often possible to deduce the coordination 
geometry from the IR spectrum. However, certain errors 
in band assignment are possible and the bridging bidentate 
complexes of orthophosphate with adjacent atoms of iron 
on the surface are not the only possible explanation for the 
spectra of phosphate species. The surface bonding of the 
alkylphosphonates could be investigated by Solid State 31P 
NMR, this technique being useful for revealing the nature 
of interaction of the phosphonic acid headgroup with the 
different metal oxides (Gao et al 1996).
In addition to the above reported methods, the nature of 
the surface interactions could also be examined by supple-
mentary techniques including atomic and chemical force 
microscopy (AFM and CFM). The ﬁ  rst technique is gener-
ally used to study the morphological changes observed for 
metal oxide surfaces after exposure to phosphate (or another 
coating) solution (Nooney et al 1998). The second one can be 
used to probe the interaction between solution phase species 
(as orthophosphate or carboxylate) and hydrous iron oxide 
colloids (Kreller et al 2002, 2003).
Electrophoretic mobility is used in this context to com-
pare the effect on zeta potential values of various coatings 
while interfacial hydrophilicity of the covered iron oxide 
particles can be investigated by interfacial tension measure-
ments (contact angles techniques) (Arias et al 2001, 2006; 
Butkus and Grasso 2001). Thermal gravimetric analysis 
(TGA) and differential scanning calorimetry (DSC) can 
also be used to investigate the formation of strong chemical 
bonds between the substrates and various molecules (Yee 
et al 1999). Modern ultra high vacuum surface analytical 
methods including X ray photoelectron spectroscopy and 
thermally programmed desorption have also been used 
to examine phosphate adsorbed on an iron oxide surface 
(Nooney et al 1996).
The physicochemical processes behind iron oxide sur-
faces interaction with phosph(on)ates have presented many 
perplexing questions for well over a century being widely 
used for water treatment purposes. Answering all these 
questions could be of great interest but, unfortunately, until 
now there is no univocal answer. The main mechanism of 
ligand adsorption is ligand exchange: the surface hydroxyl, 
Figure 3 (a) A nanoparticle grafted with long-chain fatty acids self-assembled monolayers without R functional groups. (b) A scheme of possible fatty acids (alpha linoleic 
acid) to graft into iron oxide surface particles. International Journal of Nanomedicine 2007:2(4) 616
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coming from the water to complete the coordination sphere 
of the iron, is exchanged by another ligand. Ligands are gen-
erally bonded to a metal ion on the surface by a coordinate 
covalent bond (donating electrons from a lone pair into an 
empty metal orbital), and are thus said to be coordinated 
to the ion. The extent of surface coordination and its pH 
dependence can be explained by considering the afﬁ  nity of 
the iron surface sites for ligands and the pH dependence of 
the activity of surface sites and ligands. Since the adsorption 
of anions is coupled with a release of OH− ions, adsorption 
is favored by lower pH values (Stumm 1992). Some metal 
complexes are formed by bonds that are quite strong and can 
be considered irreversible. The type and magnitude of the 
interactions between these ligands and particles surface can 
also affect the magnetic properties of the USPIOs (Vestal and 
Zhang 2003). In fact it is known that the surface chemistry 
of the USPIO particles is responsible for their magnetic 
properties because of the exceedingly high ratio of atoms at 
the surface to those within the particle. Thus, the nature of 
the interaction between the nanoparticle surface Fe3+ sites 
and the adsorbing group is an important concern. Several 
studies and hypotheses have been made taking into consid-
eration various ligands as reported by Tartaj et al (2006). 
For example, phosphonate coatings result in magnetization 
values of the iron oxide one order of magnitude lower than 
those obtained by coating with carboxylic acid or alcohol. 
The extra negative charge on the phosphonate groups cause 
the formation of stronger interaction to the surface of Fe3+ 
than carboxylate or alcohol groups. It is also suggested that 
the spin state of surface Fe3+ ions is affected by the bonded 
surfactant, through a mechanism of pπ-dπ O−P, and dπ-dπ 
Fe-P interactions and that the phosphonate empty d orbitals 
increase magnetic interactions between neighboring Fe3+ 
spins. In the case of carboxylic acid and alcohols, where the 
adsorbates have no empty d orbitals and where the oxygen 
atoms are less negatively charged, the iron is in a high spin 
state (Yee et al 1999). Nowack and Stone (1999) reported that 
the stability of metal-phosphonate complexes increases with 
increasing number of orthophosphate. Thus, the phosphonate 
complexes formed are known to be highly stable, and the 
retained coating does not readily desorb or exchange with 
competing ions in solution even at neutral pH.
A model for the binding and the structural organization 
of the alkane-phosph(on)ate molecules on the metal oxide 
surface has been proposed. It involves direct coordination of 
the terminal phosphate headgroup to metal cations forming a 
strong complexation bond, differentiating two types of bond-
ing of the alkane-phosph(on)ate with both monodentate and 
bidentate phosphate-metal cation coordinative interactions 
(Brovelli and Hähner 1999; Barja and Dos Santos Afonso 
2005). For monophosphate coating both possibilities, mono-
dentate and bidentate, seem possible but the dominating 
binding is that of phosphonate groups bridging two Fe3+ ions 
(Yee et al 1999). Zeta potential and absorption measurements 
as well as IR spectroscopy (Tejedor-Tejedor and Anderson 
1990; Persson et al 1996) have suggested that the phosphate 
ions form bidentate complexes with adjacent sites on the 
iron oxide surface.
Nanoparticles in solution: 
Properties
When USPIO are dispersed in an aqueous medium, the 
electric double layer (a diffuse layer) surrounds the particle 
carrying surface charge (Joly et al 2004). It has properties 
similar to a capacitor, with an electric potential whose abso-
lute value decays with distance from the surface. Different 
models were proposed to describe the diffuse layer (Westall 
and Hohl 1980). In general, they are based on the adsorption 
and redistribution of the ions from the bulk solution near the 
particle surface. The characteristic thickness of the double 
layer (also named the reciprocal Debye-Hückel length, κ–1) is 
related to the ionic strength of the suspension (Xu 1998). The 
existence of the shear layer has great inﬂ  uence on the stability 
of the colloidal systems and, speciﬁ  cally, the hydrodynamic 
motion of the suspended particles.
It has long been noticed that the hydrodynamic size val-
ues obtained by laser light scattering are often larger than 
diameters obtained from transmission electron microscopic 
(TEM) measurements and, for the same sample, the hydro-
dynamic size can change with the suspension conditions 
(Prescott et al 1993; Prescott et al 1997). There are many 
theories regarding the nature of this discrepancy. One is 
the “hairy layer” model that attributes the larger apparent 
size to a hairy layer formed by surface molecular chains 
(Seebergh and Berg 1995). Another is the hydration model 
that uses surface hydration and the electric double layer to 
explain the observed difference (Johnson 1993; Fischer and 
Kenndler 1997). Probably both phenomena give rise to this 
discrepancy because the water and coating electronic density 
are not surveying by TEM and X-ray diffractions techniques. 
The discrepancy between the hydrodynamic size and the 
solid dimension of the particles poses a challenge regarding 
the reliability of applying only one technique as dynamic 
light scattering which is commonly used for stability studies 
(Xu 1998). This effect is particularly relevant for USPIOs 
because there is a great difference between their crystal and International Journal of Nanomedicine 2007:2(4) 617
Physicochemical characterization of USPIO
their hydrodynamic size. Finally the question remains how 
the double layer plane location is related to the determination 
of both hydrodynamic diameter and zeta potential.
Zeta potential
Zeta-potential plays an important role in the electrokinetic 
characterization of solid–liquid interfaces; it is deﬁ  ned as the 
electrical potential at the shear plane (also known as slipping 
plane). The shear plane is a common concept in colloid sci-
ences, nevertheless it is difﬁ  cult to ﬁ  nd in the literature clear 
information concerning the determination of the shear plane 
location that remains unknown. The shear plane is commonly 
considered smaller than the double layer, despite no exact 
relationship has been formulated yet. The zeta potential is a 
function of surface charge density, shear plane location, and 
surface structure and it is a very important parameter with 
respect to many features of the dispersed materials.
One fundamental property of metal oxide surfaces is their 
tendency to build up a surface charge when in contact with 
water. That will induce electrostatic effects in the neighbor-
hood of the charged particle. Indeed, in solution, the presence 
of a net charge on a particle affects the distribution of sur-
rounding ions, resulting in an increase in the concentration 
of counter-ions (ions of opposite charge to the particle) in 
the vicinity of the particle. This implies that the double layer 
is determined by the ionic strength of the solution (Hunter 
2001). When the electrolyte concentration is modiﬁ  ed, the 
changes in the shear plane location may be caused either by 
changes in the double layer thickness and polarization or 
by modiﬁ  cation of the surface morphology. Thus, it is dif-
ﬁ  cult to differentiate the shift in the shear plane from zeta 
potential measurements in different electrolyte concentration 
conditions. As a consequence, ζ-potential cannot be mea-
sured directly, but it has to be calculated from experimental 
techniques (streaming current or potential, electrophoretic 
mobility and electric conductivity) with the help of theoreti-
cal approaches (El-Gholabzouri et al 2006). There is a new 
alternative method based on ultrasound which is rapidly 
becoming important. The ultrasound method has a large 
advantage over traditional light based techniques because it 
is able to characterize concentrated systems without dilution 
(Dukhin et al 1999). Indeed, light based methods require, in 
general, extreme dilution suspensions in order to make the 
sample sufﬁ  ciently transparent for measurement (especially 
for USPIOs samples that are mat and dark brown).
Usually, the zeta potential of colloidal suspensions is 
measured from electrokinetic techniques. An electrokinetic 
phenomenon occurs when an external ﬁ  eld acts on a colloidal 
suspension. When a particle moves in an arbitrary electrolyte 
solution, a thin liquid layer will move with the particle, too. 
The layer between the moving and stationary liquid deﬁ  nes 
the slipping plane and the potential in that plane is the elec-
trokinetic potential also called the ζ-potential. Inside the 
slip plane the particles are considered to be solid spheres 
with no bulk conductivity. The value of the ζ-potential for 
a determined charged interface should be independent of 
the electrokinetic technique used. However, there are a lot 
of reports (Russel et al 1995; Midmore et al 1996; Gusev 
and Horvath 2002) where signiﬁ  cant differences are found 
between the values of ζ-potential obtained for the same 
charged interface using different electrokinetic techniques 
or theoretical approaches. Zeta-potential values obtained 
from electric conductivity experiments are generally much 
higher than those obtained from electrophoretic mobility 
or streaming potential. Also, ζ-potentials provided from 
electrophoretic mobility measurements usually show higher 
values than those obtained from streaming potential (El-
Gholabzouri et al 2006). As a consequence, the ζ-potentials 
values obtained with different methodologies are hardly 
compared and the standardization of these measures is far 
to be achieved.
It is worth to be mentioned that if the zeta potential of 
colloidal suspensions used for medical purpose are usually 
characterized by electrophoretic methodologies, the expres-
sions relating the mobility to the ζ-potential are quite com-
plicated and it is out of question that approximate analytical 
or numerical solutions may only be obtained by properly 
deﬁ  ning appropriate boundary conditions. This has led to dif-
ferent simpliﬁ  ed expressions for relating measured mobility 
to ζ-potential, but it’s very important to keep in mind that 
many of them have restrictions on the ζ-potentials values 
and/or κa (the ratio of the particle radius to electrical double 
layer thickness) (Lyklema 1995; Hunter 2001).
Commonly used expressions in commercial instruments 
to convert the electrokinetic mobility into ζ-potential derive 
from approximations of the Henry Equation by a separate 
analytical theory of the two following cases. The ﬁ  rst case is 
represented by the most commonly used Smoluchowski equa-
tion (Thode et al 2000) which is valid for relatively conduct-
ing aqueous solutions (polar solvents) where the double layer 
is usually much thinner than the particle radius a (κa     1). 
The second opposite case (κa     1) is represented by the 
Huckel equation which is valid for low conducting liquids 
(non polar solvent). Both, deriving from Henry equation, give 
appropriate zeta potentials only for rigid spheres at quite low 
mobility values (low values of zeta potential).International Journal of Nanomedicine 2007:2(4) 618
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Despite it is possible to obtain more accurate numerical 
solutions for rigid spheres by the O’Brien and White theory 
the algorithms used are quite complicated (O’Brien and 
White 1978).
Most of the colloidal nanoparticles used for medical 
purpose are coated with polymer or polyelectrolytes and 
they cannot be really considered as rigid spheres. To take 
into account the inﬂ  uence of the coating on the zeta potential 
values, a soft particle model has been proposed (Ohshima 
1995) by combining the theory of rigid spherical colloids 
with the theory of completely permeable polyelectrolytes 
or polymers. Nevertheless, even in this case, the deﬁ  nition 
of appropriate boundary conditions is needed to solve the 
complex algorithms.
It is important to point out that when using the electropho-
retic technique the zeta potential is not measured directly, but 
calculated from the electrophoretic mobility by application 
of model equations (usually the Henry Equation or the most 
widely employed Smoluchowski one).Thus, the reliability of 
the zeta potential data depends upon the applicability of the 
equation used to the system under investigation.
However, none of the preceding theories ﬁ  ts with USPIOs 
(very small particles with an important double layer thick-
ness, strongly negative charges and coated). The deﬁ  nition of 
appropriate boundary conditions is indeed very difﬁ  cult since 
they don’t really ﬁ  t to this kind of system, and artefacts can 
result from the zeta potential measurements (Di Marco et al 
2007). An illustration of this point can be found in Di Marco 
et al 2007 where the zeta potential of different coated USPIOs 
was determined in NaCl 1 mM: a difference of about 20 mV 
was reported depending on whether the Smoluchowski or 
Hückel formula were used.
Moreover, USPIOs tend to denaturate, especially at the 
high voltage required in the case of such tiny particles to 
have a suitable sensitivity. The optimal frequency and volt-
age have then to be precisely determined to minimize this 
phenomenon.
Stability
Colloidal stability of iron oxide nanoparticles in aqueous 
suspensions is certainly one of the key points for pharma-
ceutical application.
Undoubtedly, the DLVO (Derjaguin and Landau 1941; 
Vervey and Overbeek 1948) theory extended to account for 
hydration, steric, and magnetic interactions between particles 
has been and is still very useful for investigating the stabil-
ity of colloidal dispersions (Ortega-Vinuesa et al 1996). 
According to this theory and in the absence of an external 
applied magnetic ﬁ  eld (Janssen et al 1990), the stability of 
the magnetic colloid principally depends on the balance 
between attractive (dipole-dipole van der Waals interac-
tions), VA, and repulsive forces (steric VS and electrostatic 
VE interactions) acting between the particles. This balance 
is commonly named total interaction potential (or energy 
barrier) VT between colloidal particles (Valle-Delgado et al 
2003). The VT value depends, among others, on the surface 
electric potential of the particles, the electrolyte concentration 
in the medium, the valence of the counterions, the particle 
size and the Hamaker constant. Since the electrostatic inter-
action energy is sensitive to the electrolyte concentration 
while attractive forces (VA) just depend on the particle nature, 
the stability of colloidal dispersions can be monitored by 
changing the ionic strength of the solution. In the absence 
of a sufﬁ  cient steric stabilization of the particles, an increase 
in the electrolyte concentration causes a signiﬁ  cant decrease 
of the thickness of the double layer and consequently of VT. 
Thus, an electrolyte concentration (the so-called critical 
coagulation concentration, c.c.c.) exists, at which the energy 
barrier vanishes because the repulsion forces are completely 
cancelled. Then, the colloidal dispersion becomes unstable 
above the c.c.c. (Romero-Cano et al 2001; Valle-Delgado 
et al 2003).
Since charge stabilization shows high ionic strength 
sensitivity besides the poor electrolyte resistance, steric sta-
bilization prevents the ﬂ  occulation of a colloid by attaching 
an efﬁ  cient coating onto the particle surface. Steric stabili-
zation is, therefore, a very useful method which provides 
strong stabilization even at high salt conditions and in a 
wide range of pH. In this situation, the suspension is then 
found to be stable despite zeta potential values close to zero 
(Thode et al 2000).
The efﬁ  cient coating of magnetic particles by a large 
variety of agents may provide enhanced stability by com-
bining electrostatic and steric (electrosteric) stabilization 
(Ortega-Vinuesa et al 1996). These coatings modify the 
surface properties of the magnetic nanoparticles to a certain 
degree, depending on the amount adsorbed. If sufﬁ  cient 
stabilizing agent is present, the coating layer will stabilize 
the particles in a way of combined steric and electrostatic 
effects; therefore, the colloidal stability is signiﬁ  cantly 
improved. The stability factor W of the suspension has been 
extensively used in the literature to characterize the colloidal 
stability of particles having a larger size than the USPIOs, but 
rarely for so tiny particles (Puertas and de las Nieves 1999; 
Romero-Cano et al 2001; Ishikawa et al 2005; Di Marco et al 
2007). W is given as the ratio of the rate constants for rapid International Journal of Nanomedicine 2007:2(4) 619
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and slow coagulation kinetics, respectively. The experi-
mental W-values can be used to calculate both the Hamaker 
constant (A), which characterizes the attraction between two 
particles, and the diffuse potential (ψd), which is related to 
the electrostatic repulsion. These calculations can be car-
ried out following different methods, which are described 
in the literature (Holthoff et al 1996; Ortega-Vinuesa et al 
1996; Schudel et al 1997; Puertas and de las Nieves 1999; 
Romero-Cano et al 2001), nevertheless the mathematical 
treatment taking into account the steric contribution is 
quite difﬁ  cult. A typical experimental method developed to 
investigate the colloidal stability of the particles is based on 
the study of the time evolution of the hydrodynamic particle 
size by Dynamic light scattering (DLS) as a function of the 
ionic strength (Holthoff et al 1996; Schudel et al 1997). In 
this approach, the lower limit of the temporal resolution for 
a given sample is determined by the time needed to obtain an 
autocorrelation function with sufﬁ  cient statistical accuracy. 
Noteworthy, with USPIOs, the coagulation phenomenon 
starts rapidly (Di Marco et al 2007). It is also possible to 
investigate colloidal stability as a function of the salt con-
centration by measuring the aggregation kinetics via turbidity 
measurements (Ortega-Vinuesa et al 1996; Viota et al 2005). 
Due to the tendancy of DLS to overweight large particles 
however, one will have to pay attention to the experimental 
settings such as the angle of scattered light (generally 90° but 
can be varied) and the delay time especially when different 
batches have to be compared (Thode et al 2000).
Conclusion
Although USPIOs are commonly considered for medical 
purposes, their physicochemical properties still remain insuf-
ﬁ  ciently understood. The inﬂ  uence of the coating layer on 
their structural and magnetic properties deserves further clari-
ﬁ  cation whereas the nature of the grafting is still sometimes 
under debate. Even in the case where a general agreement 
exists, as for Si−O−Fe bond, the experimental evidences are 
not sufﬁ  cient to assert it with certainty and some authors 
bring these theories into question.
Systematic studies, reporting the inﬂ  uence of polymer 
modiﬁ  cations and concentration on particle size, coating 
efﬁ  ciency, and on USPIOs stability are quite rare whereas 
zeta potential measurements are far to be standardized.
For these reasons there is an urgent need to perform fur-
ther investigations on the physicochemical characterization 
of USPIOs at the molecular and supramolecular level.
These further investigations should help to deﬁ  ne ratio-
nnal models in order to optimize the physicochemical and 
biological properties of USPIO as proposed in a recent 
work (Marinescu et al 2006) where a relationship between 
the saturation magnetization, the size of the nanoparticles 
and some simple electronic descriptors of the coating was 
established using a Quantitative Structure Property Relation-
ship analysis.
References
Anzai Y, McLachlan S, Morris M, et al. 1994. Dextran-coated superpara-
magnetic iron oxide, an MR contrast agent for assessing lymph nodes 
in the head and neck. Am J Neuroradiol, 15:87–9.
Arias JL, Gallardo V, Gomez-Lopera SA, et al. 2001. Synthesis and charac-
terization of poly(ethyl-2-cyanoacrylate) nanoparticles with a magnetic 
core. J Control Release, 77:309–21.
Arias JL, Gallardo V, Gomez-Lopera, et al. 2005. Loading of 5-ﬂ  uorouracil 
to poly(ethyl-2-cyanoacrylate) nanoparticles with a magnetic core. 
J Biomed Nanotech, 1:214–23.
Arias JL, Gallardo V, Linares-Molinero F, et al. 2006. Preparation and 
characterization of carbonyl iron/poly(butylcyanoacrylate) core/shell 
nanoparticles. J Colloid Inter Sci, 299:599–607.
Atzei D, Ferri T, Sadun C, et al. 2001. Structural characterization of com-
plexes between iminodiacetate blocked onstyrene-divinylbenzene matrix 
(Chelex 100 resin) and Fe(III), Cr(III), and Zn(II) in solid phase by 
energy-dispersive X-ray diffraction. J Am Chem Soc, 123:2552–8.
Auernheimer J, Zukowski D, Dahmen C, et al. 2005. Titanium implant 
materials with improved biocompatibility through coating with 
phosphonate-anchored cyclic RGD peptides. Chem Bio Chem, 
6:2034–40.
Babes L, Denizot B, Tanguy G, et al. 1999. Synthesis of iron oxide nanopar-
ticles used as MRI contrast agents: A parametric study. J Colloid Inter 
Sci, 212:474–82.
Barja BC, Herszaje J, Dos Santos Afonso M. 2001. Iron(III)-phosphonates 
complexes. Polyhedron, 20:1821–30.
Barja BC, Dos Santos Afonso M. 2005. Aminomethylphosphonic acid and 
glyphosate adsorption onto goethite: A comparative study. Environ 
Sci Technol, 39:585–92.
Batlle X, Labarta A. 2002. Finite-size effects in ﬁ  ne particles: magnetic and 
transport properties. J Phys D: Appl Phys, 35:R15–42.
Bautista MC, Bomati-Miguel O, Morales MD, et al. 2005. Surface charac-
terisation of dextran-coated iron oxide nanoparticles prepared by laser 
pyrolysis and coprecipitation. J Magn Magn Mater, 293:20–7.
Bellin MF, Roy C, Kinkel K, et al. 1998. Lymph node metastases: safety and 
effectiveness of MR imaging with ultrasmall superparamagnetic iron 
oxide particles. Initial clinical experience. Radiology, 207:799–08.
Bellin MF, Beigelman C, Precetti-Morel C. 2000. Iron oxide-enhanced MR 
lymphography: initial experience. Eur J Radiol, 34:257–64.
Berry CC, Curtis SG. 2003. Functionalisation of magnetic nanoparticles for 
applications in biomedicine. J Phys D: Appl Phys, 36:R198–206.
Bjornerud A, Johansson LO, Ahlstrom HK. 2001. Pre-clinical results with 
Clariscan (NC100150 Injection); experience from different disease 
models. MAGMA, 12:99–103.
Bonnemain B. 1998. Superparamagnetic agents in magnetic resonance 
imaging: physicochemical characteristics and clinical applications. 
J Drug Target, 6:167–74.
Borggaard OK, Raben-Lange B, Gimsing AL, et al. 2005. Inﬂ  uence of 
humic substances on phosphate adsorption by aluminium and iron 
oxides. Geoderma, 127:270–9.
Bourrinet P, Bengele HH, Bonnemain B, et al. 2006. Preclinical safety 
and pharmacokinetic proﬁ  le of ferumoxtran-10, an ultrasmall super-
paramagnetic iron oxide magnetic resonance contrast agent. Invest 
Radiol, 41:313–24.
Bowen CV, Zhang X, Saab G, et al. 2002. Application of the static dephas-
ing regime theory to superparamagnetic iron-oxide loaded cells. Magn 
reson med, 48:52–61.International Journal of Nanomedicine 2007:2(4) 620
Di Marco et al
Brice-Profeta S, Arrio MA, Tronc E, et al. 2005. Magnetic order in g-Fe2O3 
nanoparticles:a XMCD study. J Magn Magn Mat, 288:354–65.
Brovelli D, Hähner G. 1999. Highly oriented, self-assembled alkanephosphate 
monolayers on tantalum(V) Oxide Surfaces. Langmuir, 15:4324–7.
Butkus MA, Grasso D. 2001. The nature of surface complexation: a con-
tinuum approach. Environ Geol, 40:446–53.
Caminiti R, Carbone M, Panero S, et al. 1999. Conductivity and structure 
of poly(ethylene glycol) complexes using energydispersive X-ray dif-
fraction. J Phys Chem B, 103:10348–55.
Chatterjee J, Haik Y, Chen CJ. 2003. Size dependent magnetic properties of 
iron oxide nanoparticles. J. Magn Magn Mater, 257:113–8.
Chen Y, Liu W, Ye C, et al. 2001. Preparation and characterization of self-
assembled alkanephosphate monolayers on glass substrate coated with 
nano-TiO2 thin ﬁ  lm. Mater Res Bulletin, 36:2605–12.
Clément O, Siauve N, Cuénod CA, et al. 1998. Liver imaging with 
Ferumoxides – Feridex , fundamentals, controversies and practical 
aspects. Topics in Magnetic Reson Imaging, 9:167–82.
Corot C, Petry KG, Trivedi R, et al. 2004. Macrophage imaging in central 
nervous system and in carotid atheroscleroticplaque using ultrasmall 
superparamagnetic iron oxide in magnetic resonance imaging. Invest 
Radiol, 39:619–25.
Corot C, Robert P, Idée JM, et al. 2006. Recent advances in iron oxide 
nanocrystal technology for medical imaging. Adv Drug Deliv Rev, 
58:1471–504.
Cushing BL, Kolesnichenko VL, O’Connor CJ. 2004. Recent Advances 
in the liquid-phase syntheses of inorganic nanoparticles. Chem Rev, 
104:3893–946.
Derjaguin BV, Landau LD. 1941. Theory of the stability of strongly charged 
lyophobic sols and the adhesion of strongly charged particles in solu-
tions of electrolytes. Acta Physicochim, 14:633–62.
Di Marco M, Port M, Couvreur P, et al. 2006. Structural characterization 
of ultrasmall superparamagnetic iron oxide (USPIO) particles in aque-
ous suspension by energy dispersive X-ray diffraction (EDXD). J Am 
Chem Soc, 128:10054–9.
Di Marco M, Guilbert I, Port M, et al. 2007. Colloidal stability of ultrasmall 
superparamagnetic iron oxide (USPIO) particles with different coatings. 
Inter J Phar, 331:197–203. 
Dukhin AS, Ohshima H, Shilov VN, et al. 1999. Electroacoustics for con-
centrated dispersions. Langmuir, 15:3445–51.
El-Gholabzouri O, Cabrerizo-Vılchez MA, Hidalgo- Alvarez R. 2006. Zeta-
potential of polystyrene latex determined using different electrokinetic 
techniques in binary liquid mixtures. Colloids Surf A, 291:30–7.
Fauconnier N, Pons JN, Roger J. 1997. Thiolation of maghemite nanopar-
ticles by dimercaptosuccinic acid. J Colloid Interf Sci, 194:427–33.
Fischer CH, Kenndler EJ, 1997. Analysis of colloids IX. Investigation of 
the electrical double layer of colloidal inorganic nanometer-particles by 
size-exclusion chromatography. J Chromatogr A, 773:179–87.
Flesch C, Bourgeaut-Lami E, Mornet S, et al. 2005. Synthesis of colloidal 
superparamagnetic nanocomposites by grafting poly(e-caprolactone) 
from the surface of organosilane-modiﬁ  ed maghemite nanoparticles. 
J Polym Sci Part A: Polym Chem, 43:3221–31.
Gao W, Dickinson L, Grozinger C, et al. 1996. Self-assembled monolayers 
of alkylphosphonic acids on metal oxides. Langmuir, 12:6429–35.
Gaur U, Sahoo SK, De TK. 2002. Biodistribution of ﬂ  uoresceinated dex-
tran using novel nanoparticles evading reticuloendothelial system. Int 
J Pharm 202:1–10.
Gillis P, Koenig SH. 1987. Transverse relaxation of solvent protons induced 
by magnetized spheres : application to ferritin, erythrocytes and mag-
netite. Magn Reson Med, 5:323–45.
Gomez-Lopera SA, Arias JL, Gallardo V, et al. 2006. Colloidal stability of mag-
netite/poly(lactic acid) core/shell nanoparticles. Langmuir, 22:2816–21.
Gossuin Y, Roch A, Muller RN, et al. 2002. An evaluation of the contribu-
tions of diffusion and exchange in relaxation enhancement by MRI 
contrast agents. J Magn Res, 158:36–42.
Groman EV, Paul KG, Frigo TB, et al. 2003. Heat stable colloidal iron 
oxides coated with reduced carbohydrates and carbohydrate derivatives. 
United States Patent 6:599–498.
Gupta AK, Gupta M. 2005. Synthesis and surface engineering of iron 
oxide nanoparticles for biomedical applications. Biomaterials, 
26:3995–4021.
Gusev I, Horvath C. 2002. Streaming potential in open and packed fused-
silica capillaries. J Chromatogr A, 948:203–23.
Holthoff H, Egelhaaf SU, Borkovec M, et al. 1996. Coagulation rate mea-
surements of colloidal particles by simultaneous static and dynamic 
light scattering. Langmuir, 12:5541–49.
Hunter RJ. 2001. Foundations of colloid science. 2nd ed. Oxford: Clar-
endon Press.
Hyeon T, Lee SS, Park J, et al. 2001. Synthesis of highly crystalline and 
monodisperse maghemite nanocrystallites without a size-selection 
process. J Am Chem Soc, 123:12798–801.
Kim T, Reis L, Rajan K, et al. 2005. Magnetic behavior of iron 
oxide nanoparticle–biomolecule assembly. J Magn Magn Mater, 
295:132–8.
Kreller DI, Gibson G, Novak W, et al. 2002. Chemical force microscopy 
investigation of phosphate adsorption on the surfaces of iron(III) Oxy-
hydroxide Particles. J Colloid Interf Sci, 254:205–13.
Kreller DI, Gibson G, Novak W, et al. 2003. Competitive adsorption of 
phosphate and carboxylate with natural organic matter on hydrous 
iron oxides as investigated by chemical force microscopy. Colloids 
Surf A, 212:249–64.
Iglesias O, Labarta A. 2004. Role of surface disorder on the magnetic proper-
ties and hysteresis of nanoparticles. Physica B, 343:286–92.
Ishikawa Y, Katoh Y, Ohshima H. 2005. Colloidal stability of aqueous 
polymeric dispersions: Effect of pH and salt concentration. Colloid 
and Surf B, 42:53–8.
Janssen JJM, Baltussen JJM, van Gelder AP, et al. 1990. Kinetics of mag-
netic ﬂ  occulation. II: Flocculation of coarse particles. J Phys D: Appl 
Phys, 23:1455–60.
Johnson P. 1993. Dilute solution behavior of polystyrene latex particles and 
their interaction with Triton X-100. Langmuir, 9:2318–25.
Jolivet JP. 2000. Metal oxide chemistry and Synthesis: From solutions to 
solid State. Marcel Dekker, New York.
Joly L, Ybert C, Trizac E. 2004. Hydrodynamics within the electric double 
layer on slipping surfaces. Phys Rev Lett, 93 (257805):1–4.
Jung CW. 1995. Surface properties. of superparamagnetic iron oxide MR. 
contrast agents: ferumoxides, ferumoxtran, ferumoxsil. Magn Reson 
Imaging, 13:675–91.
Lawaczeck R, Menzel M, Pietsch H. 2004. Superparamagnetic iron oxide 
particles: contrast media for magnetic resonance imaging. Appl Organo-
metal Chem, 18:506–13.
Leenders W. 2003. Ferumoxtran-10. Drugs, 6:987–93.
Love JC, Estroff LA, Kriebel JK. 2005. Self-assembled monolayers 
of thiolates on metals as a form of nanotechnology. Chem Rev, 
105:1103–69.
Lyklema J. 1995. Fundamentals of interface and colloid science: solid-liquid 
interfaces. New York:Academic Press.
Marinescu G, Patron L, Culita DC, et al. 2006. Synthesis of magnetite in the 
presence of aminoacids. J Nanoparticules Research, 8:1045–51.
Martell AE, Smith RM, Motekaitis RJ. 1997. Critically selected stability 
constants of metals complexes database, NIST standard.
Maruno S, Hasegawa M. April 20, 1993. Organic magnetic complex. United 
States Patent 5:204–457.
Midmore BR, Pratt GV, Herrington TM. 1996. Evidence for the Validity 
of electrokinetic theory in the thin double layer region. J Colloid Interf 
Sci, 184:170–4.
Miser DE, Shin EJ, Hajaligol MR, et al. 2004. HRTEM characterization of 
phase changes and the occurrence of maghemite during catalysis by an 
iron oxide. App Cat A: Gen, 258:7–16.
Moeser GD, Green WH, Laibinis PE, et al. 2004. Structure of polymer-
stabilized magnetic ﬂ  uids: small-angle neutron scattering and mean-ﬁ  eld 
lattice modeling. Langmuir, 20:5223–34.
Molday RS, Mackenzie D. 1982. Immunospeciﬁ  c ferromagnetic iron-
dextran reagent for the labeling and magnetic separation of cells. 
J Immunol Methods, 52:353–67.International Journal of Nanomedicine 2007:2(4) 621
Physicochemical characterization of USPIO
Morales MP, Serna CJ, Bødker F, et al. 1997. Spin canting due to structural 
disorder in maghemite. J Phys: Condens Matter, 9:5461–7.
Morales MP, Veintemillas-Verdaguer S, Montero MI, et al. 1999. Surface and 
internal spin canting in -Fe2O3 nanoparticles. Chem Mater, 11:3058–64.
Mornet S, Portier J, Duguet E. 2005. A method for synthesis and function-
alization of ultrasmall superparamagnetic covalent carriers based on 
maghemite and dextran. J Magn Magn Mater, 293:127–34.
Muller RN, Roch A. 1992. In: 11th Annual Scientiﬁ  c Meeting; SMRM; 
Works in Progress; Berlin 8–14. p 1447
Nooney MG, Murrell TS, Corneille JS, et al. 1996. A spectroscopic 
investigation of phosphate adsorption onto iron oxides. J Vac Sci 
Technol A, 14:1357–61.
Nooney MG, Corneille JS, Murrell TS, et al. 1998. Nucleation and growth 
of phosphate on metal oxide thin ﬁ  lms. Langmuir, 14:2750–55.
Nowack B, Stone AT. 1999. Adsorption of phosphonates onto the goethite–
water interface. J Colloid Interf Sci, 214:20–30.
O´Brien RW, White LR. 1978. Electrophoretic mobility of a spherical col-
loidal particle. J Chem Soc Faraday Trans 2, 74:1607–26.
Ohgushi M, Nagayama K, Wada A. 1978. Dextran-magnetite: a new relax-
ation reagent and its application to T2 measurements in gel systems. 
J magn Reson, 29:599−601.
Ohshima, H. 1995. Electrophoresis of soft particles. Adv Colloid Interf 
Sci, 62:189–235.
Ortega-Vinuesa JL, Martin-Rodriguez A, Hidalgo-Alvarez R. 1996. Col-
loidal stability of polymer colloids with different interfacial properties: 
mechanisms. J Colloid Interf Sci, 184:259–67.
Pascal C, Pascal JL, Favier F, et al. 1999. Electrochemical synthesis for the 
control of γ-Fe2O3 nanoparticle size. Chem Mater, 11:141–7.
Paul GK, Frigo TB, Groman JY, et al. 2004. Synthesis of ultrasmall super-
paramagnetic iron oxides using reduced polysaccharides. Bioconjugate 
Chemistry, 15:394–401
Peng Y, Park C, Zhu JG, et al. 2004. Characterization of interfacial reactions 
in magnetite tunnel junctions with transmission electron microscopy. 
J Appl Phys, 95:6798–800.
Persson P, Nilsson N, Sjöberg S. 1996. structure and bonding of orthophosphate 
ions at the iron oxide–aqueous interface. J Colloid Interf Sci, 177:263–75.
Plaza RC, Arias JL, Espin M, et al. 2002. Aging effects in the electrokinetics 
of colloidal iron oxides. J Colloid Interf Sci, 245:86–90.
Prescott JH, Shiau SJ, Rowell RL. 1993. Characterization of polystyrene 
latexes by hydrodynamic and electrophoretic ﬁ  nger printing. Langmuir, 
9:2071–76.
Prescott JH, Rowell RL, Bassett DR. 1997. Dependence of particle size on 
pH, electrolyte, and time for expandable copolymer latexes by hydro-
dynamic ﬁ  ngerprinting. Langmuir, 13:1978–86.
Puertas AM, de las Nieves FJ, 1999. Colloidal stability of polymer colloids 
with variable surface charge. J Colloid Interf Sci, 216:221–9.
Raynal I, Prigent P, Peyramaure S, et al. 2004. Macrophage endocytosis of 
superparamagnetic iron oxide nanoparticles: mechanisms and compari-
son of ferumoxides and ferumoxtran-10. Invest Radiol, 39(1):56–63.
Reimer P, Tombach B. 1998. Hepatic MRI with SPIO, detection and char-
acterization of focal liver lesions. Eur Radiol, 8:1198–204.
Roch A, Muller RN, Gillis P. 1999. Theory of proton relaxation Induced by 
superparamagnetic particles. J Chem Phys, 110:5403–11.
Roch A, Gossuin Y, Muller RN, et al. 2005. Superparamagnetic colloid 
suspensions: Water magnetic relaxation and clustering. J Magn Magn 
Mater, 293:532–9.
Roger J, Pons JN, Massart R, et al.1999. Some biomedical applications of 
ferroﬂ  uids. Eur Phys J AP, 5:321–5.
Romero-Cano MS, Martın-Rodrıguez A, de las Nieves FJ. 2001. Elec-
trosteric stabilization of polymer colloids with different functionality. 
Langmuir, 17:3505–11.
Russel AS, Scales PJ, Mangelsdorf CS, et al. 1995. High-frequency dielectric 
response of highly charged sulfonate latices. Langmuir, 11:1553–58.
Sadun C, Bucci R, Magrı AL. 2002. Structural analysis of the solid 
amorphous binuclear complexes of Iron(III) and Aluminum(III) with 
Chromium(III)-DTPA chelator using energy dispersive X-ray Diffrac-
tion. J Am Chem Soc, 124:3036–41.
Sahoo Y, Pizem H, Fried T, et al. 2001. Alkyl phosphonate/phosphate 
coating on magnetite nanoparticles: a comparison with fatty acids. 
Langmuir, 17:7907–11.
Schudel M, Behrens SH, Holthoff  H, et al. 1997. Absolute aggregation rate 
constants of hematite particles in aqueous suspensions: A comparison of 
two different surface morphologies. J Colloid Interf Sci, 196:241–53.
Seebergh JE, Berg JC. 1995. Evidence of a hairy layer at the surface of 
polystyrene latex particles. Colloids Surf A, 100:139–53.
Serna CJ, Bodker F, Morup S, et al. 2001. Spin frustration in maghemite 
nanoparticles. Solid State Commun, 118:437–40.
Shen L, Stachowiak A, Fateen SEK, et al. 2001. Structure of alkanoic acid 
stabilized magnetic ﬂ  uids. A small-angle neutron and light scattering 
analysis. Langmuir, 17:288–99.
Sonvico F, Dubernet C, Colombo P, et al. 2005. Metallic colloid nano-
technology, applications in diagnosis and therapeutics. Curr Pharm 
Design, 11:2095–105.
Sonvico F, Mornet S, Vasseur S, et al. 2005. Folate-conjugated Iron Oxide 
nanoparticles for solid tumor targeting as potential “speciﬁ  c magnetic 
hyperthermia mediators: synthesis, physicochemical characterization, 
and in vitro experiments. Bioconjug Chem, 16:1181–8.
Stumm W. 1992. Chemistry of the solid-water interface. New York: Wiley 
& Sons.
Tartaj P, Morales MP, Veintemillas-Verdaguer S, et al. 2003. The prepara-
tion of magnetic nanoparticles for applications in biomedicine. J Phys 
D: Appl Phys, 36:R182–97.
Tartaj P, Morales MP, Veintemillas-Verdaguer S, et al. 2005. Advances in 
magnetic nanoparticles for biotechnology applications. J Magn Magn 
Mater, 290:28–34.
Tartaj P, Morales MP, Veintemillas-Verdaguer S, et al. 2006. Synthesis, proper-
ties and biomedical applications of magnetic nanoparticles. In: Buschow 
KHJ, ed. Handbook of magnetic materials, Vol. 16. Elsevier, p 403–82.
Taupitz M, Wagner S, Schnorr J, et al. 2004. Phase I clinical evaluation of 
citrate-coated monocrystalline very small superparamagnetic iron oxide 
particles as a new contrast medium for magnetic resonance imaging. 
Invest Radiol, 39:394–405.
Tejedor-Tejedor MI, Anderson MA. 1990. Protonation of phosphate on 
the surface of goethite as studied by CIR-FTIR and electrophoretic 
mobility. Langmuir, 6:602–11.
Textor M, Ruiz L, Hofer R, et al. 2000. Structural chemistry of self-
assembled monolayers of octadecylphosphoric acid on tantalum oxide 
surfaces. Langmuir, 16:3257–71.
Thode K, Muller RH, Kresse M. 2000. Two-time window and multiangle photon 
correlation spectroscopy size and zeta potential analysis – highly sensitive 
rapid assay for dispersion stability. J Pharm Sci, 89:1317–24.
Tirrell M, Kokkoli E, Biesalski M. 2002. The role of surface science in 
bioengineered materials. Surface Science, 500:61–83.
Ulman A. 1996. Formation and Structure of Self-Assembled Monolayers. 
Chem Rev, 96:1533–54.
Valle-Delgado JJ, Molina-Bolıvar JA, Galisteo-Gonzalez F, et al. 2003. 
Study of the colloidal stability of an amphoteric latex. Colloid Polym 
Sci, 81:708–15.
Vervey EJW, Overbeek JTG. 1948. Theory of stability of lyophobic col-
loids. Amsterdam: Elsevier.
Vestal CR, Zhang ZJ. 2003. Effects of surface coordination chemistry on 
the magnetic properties of MnFe2O4 spinel ferrite nanoparticles. J Am 
Chem Soc, 125:9828–33.
Viota JL, de Vicente J, Durán JDG, et al. 2005. Stabilization of magne-
torheological suspensions by polyacrylic acid polymers. J coll interf 
sci, 284:527–41.
Wapner K, Grundmeier G. 2005. Spectroscopic analysis of the interface 
chemistry of ultra-thin plasma polymer ﬁ  lms on iron. Surface & Coat-
ings Technology, 200:100–3.
Weissleder R, Elizondo G, Wittenberg J, et al. 1990. Ultrasmall superpara-
magnetic iron oxide: characterization of a new class of contrast agents 
for MR imaging. Radiology, 175:489–93.
Westall J, Hohl H. 1980. A comparison of electrostatic models for the 
oxide/solution interface. Adv Colloid Interface Sci, 12:265–94.International Journal of Nanomedicine 2007:2(4) 622
Di Marco et al
White MA, Johnson JA, Koberstein JT. 2006. Toward the syntheses of uni-
versal ligands for metal oxide surfaces: controlling surface functionality 
through click chemistry. J Am Chem Soc, 128:11356–7.
Xu R. 1998. Shear plane and hydrodynamic diameter of microspheres in 
suspension. Langmuir, 14:2593–7.
Yee C, Kataby G, Ulman A, et al. 1999. Self-assembled monolayers of 
alkanesulfonic and -phosphonic acids on amorphous iron oxide nanopar-
ticles. Langmuir, 15:7111–5.
Zeng L, Li X, Liu J. 2004. Adsorptive removal of phosphate from aqueous 
solutions using iron oxide tailings. Water Research, 38:1318–26.
Zhang Y, Kohler N, Zhang M. 2002. Functionalisation of magnetic nanopar-
ticles for applications in biomedicine. Biomaterials, 23:1553–61.